Fidelity MSCI Health Care Index ETF (FHLC): outlook, holdings and fees
Fidelity MSCI Health Care Index ETF (FHLC) is an exchange-traded fund and is managed by Fidelity Investments. The expense ratio is 0.07% and the yield is 1.26%. The ten largest holdings are 51% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on FHLC
| Last price | $88.18 (-0.4%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 54% |
| Likely 1-month range (50%) | $86.02 – $91.23 |
| Normal 1-day range (±1σ) | ±1.0% |
| Distribution yield | 1.26% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
FHLC fund facts
| Issuer | Fidelity Investments |
|---|---|
| Theme | Healthcare |
| Assets under management | $3.5B |
| Expense ratio | 0.07% |
| Number of holdings | 49 |
| Portfolio turnover | 6% |
| Inception | Oct 21, 2013 |
| Exchange | NYSE |
The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care 25/50 Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care 25/50 Index. The fund is non-diversified.
FHLC top holdings
| Holding | Sector | Weight |
|---|---|---|
| Eli Lilly and Company LLY | Healthcare | 12.54% |
| Johnson & Johnson JNJ | Healthcare | 8.47% |
| AbbVie Inc ABBV | Healthcare | 6.74% |
| Merck & Company Inc MRK | Healthcare | 5.10% |
| UnitedHealth Group Incorporated UNH | Healthcare | 4.93% |
| Thermo Fisher Scientific Inc TMO | Healthcare | 3.29% |
| Amgen Inc AMGN | Healthcare | 3.05% |
| Gilead Sciences Inc GILD | Healthcare | 2.59% |
| Abbott Laboratories ABT | Healthcare | 2.30% |
| Pfizer Inc PFE | Healthcare | 2.25% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
FHLC sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 99.6%, United Kingdom 0.3%, Europe Developed 0.1%.
FHLC returns and risk
| Year to date | +12.4% |
|---|---|
| 1 year | +21.5% |
| 3 years (annualised) | +11.5% |
| 5 years (annualised) | +7.0% |
| 10 years (annualised) | +10.6% |
| Volatility (3 years) | 13.5% |
| Sharpe ratio (3 years) | 0.56 |
Past returns do not guarantee future results.
FHLC: frequently asked questions
What does FHLC invest in?
Fidelity MSCI Health Care Index ETF invests in a portfolio of securities. Its largest holdings are Eli Lilly and Company (12.5%), Johnson & Johnson (8.5%), AbbVie Inc (6.7%), Merck & Company Inc (5.1%), UnitedHealth Group Incorporated (4.9%).
What is the FHLC expense ratio?
0.07% a year: about $7.00 for every $10,000 invested.
What is the FHLC dividend yield?
1.26%. ATLAS does not hold the exact distribution dates for ETFs.
Will FHLC go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 54%, with a likely range (50%) of $86.02 to $91.23 from $88.18 today. It is a probability, not a prediction.
How has FHLC performed?
Year to date +12.4%, one year +21.5%, three years +11.5% a year, five years +7.0% a year. Past returns do not guarantee future results.
Similar ETFs: Healthcare
- State Street Health Care Select Sector SPDR ETF (XLV)
- Vanguard Health Care ETF (VHT)
- iShares Global Healthcare ETF (IXJ)
- iShares U.S. Healthcare ETF (IYH)
- iShares U.S. Medical Devices ETF (IHI)
- iShares U.S. Pharmaceuticals ETF (IHE)
- First Trust Health Care AlphaDEX Fund (FXH)
- First Trust Nasdaq Pharmaceuticals ETF (FTXH)
Educational information, not investment advice. Disclaimer